Mega Contracts Monitor ($100M+) — June 23, 2026

Analogic Corp's competitive win for full-sized CT systems under full and open competition signals strong market position in airport security; the 11-year performance period provides predictable revenue and option exercise upside.

Despite being the largest contract in the digest, only 2% of the total value has been funded, indicating early-stage milestone payments; the small, foreign-owned contractor profile raises scalability and investor confidence concerns.

The cost-plus-fixed-fee contract with NCI/NIAID VRC is ending; a follow-on award or new competition will determine whether Leidos retains ~$30M annual revenue stream in health R&D.

START2 GROUP, INC. has only $2.8M outlayed on a $141.3M contract, signaling milestone-dependent cash flow and potential delays in biotechnology R&D deliverables.

Two of three contracts (62% of total value) are with HHS agencies (BARDA and NIH), creating civilian health sector concentration risk for investors tracking government services exposure.

Leidos Biomedical Research's NIH contract expires August 2024; full and open competition on the original award means incumbency does not guarantee renewal, risking revenue loss.

Analogic Corp's TSA CT system contract positions the company for follow-on orders as TSA expands full-sized CT deployment across U.S. airports; the $499.7M ceiling provides significant upside if options are exercised.

START2 GROUP, INC.'s BARDA contract aligns with sustained biodefense funding priorities; successful milestone execution could unlock the remaining $138.5M and establish the company as a credible biotech R&D partner.

Leidos' expiring NIH contract creates a re-compete opportunity; if Leidos retains the award, it secures ~$30M annual revenue; if lost, competitors gain entry to NIAID VRC research funding.

Two of three contracts (62% of total value) are HHS awards for biotechnology and health R&D services, demonstrating that civilian agency spending—particularly at BARDA and NIH—remains a stable revenue source for government contractors.

Analogic Corp's 11-year TSA CT system contract reflects sustained federal investment in advanced detection systems, with a $499.7M ceiling indicating multi-year procurement commitments.

{"entity"=>"Analogic Corp", "reason"=>"TSA CT system contract provides long-term revenue visibility; option exercises could unlock additional $361.4M in potential value.", "trigger"=>"TSA option year exercise announcements; quarterly earnings revenue recognition from this delivery order"}

{"entity"=>"Leidos Holdings, Inc.", "reason"=>"NIH contract expires August 2024; re-compete outcome will impact ~$30M annual health R&D revenue.", "trigger"=>"NIH solicitation for follow-on NIAID VRC research services; award announcement"}

{"entity"=>"START2 GROUP, INC.", "reason"=>"High execution risk on $141.3M BARDA contract with only 2% outlayed; milestone progress is critical.", "trigger"=>"USASpending.gov outlay updates; BARDA program milestone announcements"}

{"entity"=>"HHS civilian health R&D sector", "reason"=>"Two contracts totaling $262.8M concentrated in HHS; any CR or budget cuts could delay funding.", "trigger"=>"FY2025 HHS appropriations; CR duration and impact on BARDA/NIH discretionary spending"}